APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biopharmaceutical Logistic

Biopharmaceutical Logistics is the logistics of Biopharmaceutical, medical and surgical supplies, and other products needed to support doctors, nurses, and other health and dental care providers. Because it’s final customers are responsible for the lives and health of their patients, medical logistics is unique in that it seeks to optimize effectiveness rather than efficiency. Medical logistics functions comprise an important part of the health care system: after staff costs, medical supplies are the single most expensive component of health care. To drive costs out of the health-care sector, medical logistics providers are adopting supply chain management theories.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Biopharmaceutical Logistics is the logistics of Biopharmaceutical, medical and surgical supplies, and other products needed to support doctors, nurses, and other health and dental care providers. Because it’s final customers are responsible for the lives and health of their patients, medical logistics is unique in that it seeks to optimize effectiveness rather than efficiency. Medical logistics functions comprise an important part of the health care system: after staff costs, medical supplies are the single most expensive component of health care. To drive costs out of the health-care sector, medical logistics providers are adopting supply chain management theories.

Selected research

Market Analysis & Forecast

Global Biopharmaceutical Logistic Market Analysis and Forecast 2026-2032

25 December 2025209 pages

Choose your research edition.

Industry ResearchBiopharmaceutical Logistic Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Biopharmaceutical Logistic Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Biopharmaceutical Logistic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biopharmaceutical Logistic Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Biopharmaceutical Logistic Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

Biopharmaceutical Logistics is the logistics of Biopharmaceutical, medical and surgical supplies, and other products needed to support doctors, nurses, and other health and dental care providers. Because it’s final customers are responsible for the lives and health of their patients, medical logistics is unique in that it seeks to optimize effectiveness rather than efficiency. Medical logistics functions comprise an important part of the health care system: after staff costs, medical supplies are the single most expensive component of health care. To drive costs out of the health-care sector, medical logistics providers are adopting supply chain management theories.

Market competition is intense. Deutsche Post DHL, Kuehne + Nagel, FedEx, AmerisourceBergen, UPS (Marken) and DB Schenker, etc. are the leaders of the industry, and they hold key technologies, with high-end customers; have been formed in the monopoly position in the industry. The top six players got about 20% market shares. North America is the largest consumption place, with a consumption market share nearly 34%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.

Report Includes

Read the full market overview

This report presents an overview of global market for Biopharmaceutical Logistic, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biopharmaceutical Logistic, also provides the revenue of main regions and countries. Of the upcoming market potential for Biopharmaceutical Logistic, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biopharmaceutical Logistic revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biopharmaceutical Logistic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biopharmaceutical Logistic revenue, projected growth trends, production technology, application and end-user industry.

Biopharmaceutical Logistic Segment by Company

Deutsche Post DHL

Kuehne + Nagel

FedEx

AmerisourceBergen

UPS (Marken)

DB Schenker

XPO Logistics

Panalpina

Nippon Express

GEODIS

VersaCold

Agility

DSV

Sinotrans

Kerry Logistics

SF Express

CEVA

CH Robinson

Air Canada Cargo

Biopharmaceutical Logistic Segment by Type

Cold Chain Logistics

Non-cold Chain Logistics

Biopharmaceutical Logistic Segment by Application

Ground Shipping

Sea Shipping

Air Shipping

Biopharmaceutical Logistic Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical Logistic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical Logistic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical Logistic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biopharmaceutical Logistic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biopharmaceutical Logistic company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biopharmaceutical Logistic revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biopharmaceutical Logistic Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cold Chain Logistics Major Player Table 3. Non-cold Chain Logistics Major Player Table 4. Global Biopharmaceutical Logistic Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Ground Shipping Major Player Table 6. Sea Shipping Major Player Table 7. Air Shipping Major Player Table 8. Biopharmaceutical Logistic Industry Trends Table 9. Biopharmaceutical Logistic Industry Drivers Table 10. Biopharmaceutical Logistic Industry Opportunities and Challenges Table 11. Biopharmaceutical Logistic Industry Restraints Table 12. Global Biopharmaceutical Logistic Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Biopharmaceutical Logistic Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Biopharmaceutical Logistic Market Share by Region (2021-2026) Table 15. Global Biopharmaceutical Logistic Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Biopharmaceutical Logistic Market Share by Region (2027-2032) Table 17. Global Biopharmaceutical Logistic Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Biopharmaceutical Logistic Revenue Market Share by Players (2021-2026) Table 19. Global Biopharmaceutical Logistic Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Biopharmaceutical Logistic Key Players Headquarters & Area Served Table 21. Global Biopharmaceutical Logistic Players, Product Type & Application Table 22. Global Biopharmaceutical Logistic Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Biopharmaceutical Logistic by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Biopharmaceutical Logistic Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Biopharmaceutical Logistic Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Biopharmaceutical Logistic Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Biopharmaceutical Logistic Revenue Market Share by Type (2021-2026) Table 29. Global Biopharmaceutical Logistic Revenue Market Share by Type (2027-2032) Table 30. Global Biopharmaceutical Logistic Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Biopharmaceutical Logistic Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Biopharmaceutical Logistic Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Biopharmaceutical Logistic Revenue Market Share by Application (2021-2026) Table 34. Global Biopharmaceutical Logistic Revenue Market Share by Application (2027-2032) Table 35. Deutsche Post DHL Company Information Table 36. Deutsche Post DHL Business Overview Table 37. Deutsche Post DHL Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Deutsche Post DHL Biopharmaceutical Logistic Product Portfolio Table 39. Deutsche Post DHL Recent Development Table 40. Kuehne + Nagel Company Information Table 41. Kuehne + Nagel Business Overview Table 42. Kuehne + Nagel Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Kuehne + Nagel Biopharmaceutical Logistic Product Portfolio Table 44. Kuehne + Nagel Recent Development Table 45. FedEx Company Information Table 46. FedEx Business Overview Table 47. FedEx Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. FedEx Biopharmaceutical Logistic Product Portfolio Table 49. FedEx Recent Development Table 50. AmerisourceBergen Company Information Table 51. AmerisourceBergen Business Overview Table 52. AmerisourceBergen Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. AmerisourceBergen Biopharmaceutical Logistic Product Portfolio Table 54. AmerisourceBergen Recent Development Table 55. UPS (Marken) Company Information Table 56. UPS (Marken) Business Overview Table 57. UPS (Marken) Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. UPS (Marken) Biopharmaceutical Logistic Product Portfolio Table 59. UPS (Marken) Recent Development Table 60. DB Schenker Company Information Table 61. DB Schenker Business Overview Table 62. DB Schenker Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. DB Schenker Biopharmaceutical Logistic Product Portfolio Table 64. DB Schenker Recent Development Table 65. XPO Logistics Company Information Table 66. XPO Logistics Business Overview Table 67. XPO Logistics Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. XPO Logistics Biopharmaceutical Logistic Product Portfolio Table 69. XPO Logistics Recent Development Table 70. Panalpina Company Information Table 71. Panalpina Business Overview Table 72. Panalpina Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Panalpina Biopharmaceutical Logistic Product Portfolio Table 74. Panalpina Recent Development Table 75. Nippon Express Company Information Table 76. Nippon Express Business Overview Table 77. Nippon Express Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Nippon Express Biopharmaceutical Logistic Product Portfolio Table 79. Nippon Express Recent Development Table 80. GEODIS Company Information Table 81. GEODIS Business Overview Table 82. GEODIS Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. GEODIS Biopharmaceutical Logistic Product Portfolio Table 84. GEODIS Recent Development Table 85. VersaCold Company Information Table 86. VersaCold Business Overview Table 87. VersaCold Biopharmaceutical Logistic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. VersaCold Biopharmaceutical Logistic Product Portfolio Table 89. VersaCold Recent Development Table 90. Agility Company Information Table 91. Agility Business Overview Table 92. Agility Biopharmaceutical Logistic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Agility Biopharmaceutical Logistic Product Portfolio Table 94. Agility Recent Development Table 95. DSV Company Information Table 96. DSV Business Overview Table 97. DSV Biopharmaceutical Logistic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. DSV Biopharmaceutical Logistic Product Portfolio Table 99. DSV Recent Development Table 100. Sinotrans Company Information Table 101. Sinotrans Business Overview Table 102. Sinotrans Biopharmaceutical Logistic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Sinotrans Biopharmaceutical Logistic Product Portfolio Table 104. Sinotrans Recent Development Table 105. Kerry Logistics Company Information Table 106. Kerry Logistics Business Overview Table 107. Kerry Logistics Biopharmaceutical Logistic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. Kerry Logistics Biopharmaceutical Logistic Product Portfolio Table 109. Kerry Logistics Recent Development Table 110. SF Express Company Information Table 111. SF Express Business Overview Table 112. SF Express Biopharmaceutical Logistic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. SF Express Biopharmaceutical Logistic Product Portfolio Table 114. SF Express Recent Development Table 115. CEVA Company Information Table 116. CEVA Business Overview Table 117. CEVA Biopharmaceutical Logistic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 118. CEVA Biopharmaceutical Logistic Product Portfolio Table 119. CEVA Recent Development Table 120. CH Robinson Company Information Table 121. CH Robinson Business Overview Table 122. CH Robinson Biopharmaceutical Logistic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 123. CH Robinson Biopharmaceutical Logistic Product Portfolio Table 124. CH Robinson Recent Development Table 125. Air Canada Cargo Company Information Table 126. Air Canada Cargo Business Overview Table 127. Air Canada Cargo Biopharmaceutical Logistic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 128. Air Canada Cargo Biopharmaceutical Logistic Product Portfolio Table 129. Air Canada Cargo Recent Development Table 130. North America Biopharmaceutical Logistic Revenue by Type (2021-2026) & (US$ Million) Table 131. North America Biopharmaceutical Logistic Revenue by Type (2027-2032) & (US$ Million) Table 132. North America Biopharmaceutical Logistic Revenue by Application (2021-2026) & (US$ Million) Table 133. North America Biopharmaceutical Logistic Revenue by Application (2027-2032) & (US$ Million) Table 134. North America Biopharmaceutical Logistic Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Biopharmaceutical Logistic Revenue by Country (2021-2026) & (US$ Million) Table 136. North America Biopharmaceutical Logistic Revenue by Country (US$ Million) & (2027-2032) Table 137. Europe Biopharmaceutical Logistic Revenue by Type (2021-2026) & (US$ Million) Table 138. Europe Biopharmaceutical Logistic Revenue by Type (2027-2032) & (US$ Million) Table 139. Europe Biopharmaceutical Logistic Revenue by Application (2021-2026) & (US$ Million) Table 140. Europe Biopharmaceutical Logistic Revenue by Application (2027-2032) & (US$ Million) Table 141. Europe Biopharmaceutical Logistic Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe Biopharmaceutical Logistic Revenue by Country (2021-2026) & (US$ Million) Table 143. Europe Biopharmaceutical Logistic Revenue by Country (US$ Million) & (2027-2032) Table 144. China Biopharmaceutical Logistic Revenue by Type (2021-2026) & (US$ Million) Table 145. China Biopharmaceutical Logistic Revenue by Type (2027-2032) & (US$ Million) Table 146. China Biopharmaceutical Logistic Revenue by Application (2021-2026) & (US$ Million) Table 147. China Biopharmaceutical Logistic Revenue by Application (2027-2032) & (US$ Million) Table 148. Asia Biopharmaceutical Logistic Revenue by Type (2021-2026) & (US$ Million) Table 149. Asia Biopharmaceutical Logistic Revenue by Type (2027-2032) & (US$ Million) Table 150. Asia Biopharmaceutical Logistic Revenue by Application (2021-2026) & (US$ Million) Table 151. Asia Biopharmaceutical Logistic Revenue by Application (2027-2032) & (US$ Million) Table 152. Asia Biopharmaceutical Logistic Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Asia Biopharmaceutical Logistic Revenue by Region (US$ Million) & (2021-2026) Table 154. Asia Biopharmaceutical Logistic Revenue by Region (US$ Million) & (2027-2032) Table 155. SAMEA Biopharmaceutical Logistic Revenue by Type (2021-2026) & (US$ Million) Table 156. SAMEA Biopharmaceutical Logistic Revenue by Type (2027-2032) & (US$ Million) Table 157. SAMEA Biopharmaceutical Logistic Revenue by Application (2021-2026) & (US$ Million) Table 158. SAMEA Biopharmaceutical Logistic Revenue by Application (2027-2032) & (US$ Million) Table 159. SAMEA Biopharmaceutical Logistic Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. SAMEA Biopharmaceutical Logistic Revenue by Country (2021-2026) & (US$ Million) Table 161. SAMEA Biopharmaceutical Logistic Revenue by Country (US$ Million) & (2027-2032) Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Biopharmaceutical Logistic Image Figure 2. Global Biopharmaceutical Logistic Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biopharmaceutical Logistic Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cold Chain Logistics Image Figure 5. Non-cold Chain Logistics Image Figure 6. Global Biopharmaceutical Logistic Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Biopharmaceutical Logistic Market Size Share 2021 VS 2025 VS 2032 Figure 8. Ground Shipping Image Figure 9. Sea Shipping Image Figure 10. Air Shipping Image Figure 11. Global Biopharmaceutical Logistic Market Size (US$ Million) & (2021-2032) Figure 12. Global Biopharmaceutical Logistic Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Biopharmaceutical Logistic Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Biopharmaceutical Logistic Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Biopharmaceutical Logistic Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Biopharmaceutical Logistic Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Biopharmaceutical Logistic Revenue Market Share by Type (2021-2032) Figure 19. Global Biopharmaceutical Logistic Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Biopharmaceutical Logistic Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Biopharmaceutical Logistic Revenue Market Share by Application (2021-2032) Figure 22. North America Biopharmaceutical Logistic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Biopharmaceutical Logistic Revenue Share by Type (2021-2032) Figure 24. North America Biopharmaceutical Logistic Revenue Share by Application (2021-2032) Figure 25. North America Biopharmaceutical Logistic Revenue Share by Country (2021-2032) Figure 26. United States Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Biopharmaceutical Logistic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Biopharmaceutical Logistic Revenue Share by Type (2021-2032) Figure 31. Europe Biopharmaceutical Logistic Revenue Share by Application (2021-2032) Figure 32. Europe Biopharmaceutical Logistic Revenue Share by Country (2021-2032) Figure 33. Germany Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Biopharmaceutical Logistic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Biopharmaceutical Logistic Revenue Share by Type (2021-2032) Figure 43. China Biopharmaceutical Logistic Revenue Share by Application (2021-2032) Figure 44. Asia Biopharmaceutical Logistic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Biopharmaceutical Logistic Revenue Share by Type (2021-2032) Figure 46. Asia Biopharmaceutical Logistic Revenue Share by Application (2021-2032) Figure 47. Asia Biopharmaceutical Logistic Revenue Share by Region (2021-2032) Figure 48. Japan Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Biopharmaceutical Logistic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Biopharmaceutical Logistic Revenue Share by Type (2021-2032) Figure 56. SAMEA Biopharmaceutical Logistic Revenue Share by Application (2021-2032) Figure 57. SAMEA Biopharmaceutical Logistic Revenue Share by Country (2021-2032) Figure 58. Brazil Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Cold Chain Logistics
  • Non-cold Chain Logistics
Applications
  • Ground Shipping
  • Sea Shipping
  • Air Shipping
Companies covered
  • Deutsche Post DHL
  • Kuehne + Nagel
  • FedEx
  • AmerisourceBergen
  • UPS (Marken)
  • DB Schenker
  • XPO Logistics
  • Panalpina
  • Nippon Express
  • GEODIS
  • VersaCold
  • Agility
  • DSV
  • Sinotrans
  • Kerry Logistics
  • SF Express
  • CEVA
  • CH Robinson
  • Air Canada Cargo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biopharmaceutical Logistic Market by Type
  3. 1.2.1 Global Biopharmaceutical Logistic Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cold Chain Logistics
  5. 1.2.3 Non-cold Chain Logistics
  6. 1.3 Biopharmaceutical Logistic Market by Application
  7. 1.3.1 Global Biopharmaceutical Logistic Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Ground Shipping
  9. 1.3.3 Sea Shipping
  10. 1.3.4 Air Shipping
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Biopharmaceutical Logistic Market Dynamics
  1. 2.1 Biopharmaceutical Logistic Industry Trends
  2. 2.2 Biopharmaceutical Logistic Industry Drivers
  3. 2.3 Biopharmaceutical Logistic Industry Opportunities and Challenges
  4. 2.4 Biopharmaceutical Logistic Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biopharmaceutical Logistic Market Perspective (2021-2032)
  2. 3.2 Global Biopharmaceutical Logistic Growth Trends by Region
  3. 3.2.1 Global Biopharmaceutical Logistic Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biopharmaceutical Logistic Market Size by Region (2021-2026)
  5. 3.2.3 Global Biopharmaceutical Logistic Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biopharmaceutical Logistic Revenue by Players
  2. 4.1.1 Global Biopharmaceutical Logistic Revenue by Players (2021-2026)
  3. 4.1.2 Global Biopharmaceutical Logistic Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biopharmaceutical Logistic Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biopharmaceutical Logistic Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biopharmaceutical Logistic Key Players Headquarters & Area Served
  7. 4.4 Global Biopharmaceutical Logistic Players, Product Type & Application
  8. 4.5 Global Biopharmaceutical Logistic Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biopharmaceutical Logistic Market CR5 and HHI
  11. 4.6.3 2025 Biopharmaceutical Logistic Tier 1, Tier 2, and Tier 3
5 Biopharmaceutical Logistic Market Size by Type
  1. 5.1 Global Biopharmaceutical Logistic Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biopharmaceutical Logistic Revenue by Type (2021-2032)
  3. 5.3 Global Biopharmaceutical Logistic Revenue Market Share by Type (2021-2032)
6 Biopharmaceutical Logistic Market Size by Application
  1. 6.1 Global Biopharmaceutical Logistic Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biopharmaceutical Logistic Revenue by Application (2021-2032)
  3. 6.3 Global Biopharmaceutical Logistic Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Deutsche Post DHL
  2. 7.1.1 Deutsche Post DHL Company Information
  3. 7.1.2 Deutsche Post DHL Business Overview
  4. 7.1.3 Deutsche Post DHL Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Deutsche Post DHL Biopharmaceutical Logistic Product Portfolio
  6. 7.1.5 Deutsche Post DHL Recent Developments
  7. 7.2 Kuehne + Nagel
  8. 7.2.1 Kuehne + Nagel Company Information
  9. 7.2.2 Kuehne + Nagel Business Overview
  10. 7.2.3 Kuehne + Nagel Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Kuehne + Nagel Biopharmaceutical Logistic Product Portfolio
  12. 7.2.5 Kuehne + Nagel Recent Developments
  13. 7.3 FedEx
  14. 7.3.1 FedEx Company Information
  15. 7.3.2 FedEx Business Overview
  16. 7.3.3 FedEx Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  17. 7.3.4 FedEx Biopharmaceutical Logistic Product Portfolio
  18. 7.3.5 FedEx Recent Developments
  19. 7.4 AmerisourceBergen
  20. 7.4.1 AmerisourceBergen Company Information
  21. 7.4.2 AmerisourceBergen Business Overview
  22. 7.4.3 AmerisourceBergen Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  23. 7.4.4 AmerisourceBergen Biopharmaceutical Logistic Product Portfolio
  24. 7.4.5 AmerisourceBergen Recent Developments
  25. 7.5 UPS (Marken)
  26. 7.5.1 UPS (Marken) Company Information
  27. 7.5.2 UPS (Marken) Business Overview
  28. 7.5.3 UPS (Marken) Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  29. 7.5.4 UPS (Marken) Biopharmaceutical Logistic Product Portfolio
  30. 7.5.5 UPS (Marken) Recent Developments
  31. 7.6 DB Schenker
  32. 7.6.1 DB Schenker Company Information
  33. 7.6.2 DB Schenker Business Overview
  34. 7.6.3 DB Schenker Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  35. 7.6.4 DB Schenker Biopharmaceutical Logistic Product Portfolio
  36. 7.6.5 DB Schenker Recent Developments
  37. 7.7 XPO Logistics
  38. 7.7.1 XPO Logistics Company Information
  39. 7.7.2 XPO Logistics Business Overview
  40. 7.7.3 XPO Logistics Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  41. 7.7.4 XPO Logistics Biopharmaceutical Logistic Product Portfolio
  42. 7.7.5 XPO Logistics Recent Developments
  43. 7.8 Panalpina
  44. 7.8.1 Panalpina Company Information
  45. 7.8.2 Panalpina Business Overview
  46. 7.8.3 Panalpina Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Panalpina Biopharmaceutical Logistic Product Portfolio
  48. 7.8.5 Panalpina Recent Developments
  49. 7.9 Nippon Express
  50. 7.9.1 Nippon Express Company Information
  51. 7.9.2 Nippon Express Business Overview
  52. 7.9.3 Nippon Express Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Nippon Express Biopharmaceutical Logistic Product Portfolio
  54. 7.9.5 Nippon Express Recent Developments
  55. 7.10 GEODIS
  56. 7.10.1 GEODIS Company Information
  57. 7.10.2 GEODIS Business Overview
  58. 7.10.3 GEODIS Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  59. 7.10.4 GEODIS Biopharmaceutical Logistic Product Portfolio
  60. 7.10.5 GEODIS Recent Developments
  61. 7.11 VersaCold
  62. 7.11.1 VersaCold Company Information
  63. 7.11.2 VersaCold Business Overview
  64. 7.11.3 VersaCold Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  65. 7.11.4 VersaCold Biopharmaceutical Logistic Product Portfolio
  66. 7.11.5 VersaCold Recent Developments
  67. 7.12 Agility
  68. 7.12.1 Agility Company Information
  69. 7.12.2 Agility Business Overview
  70. 7.12.3 Agility Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Agility Biopharmaceutical Logistic Product Portfolio
  72. 7.12.5 Agility Recent Developments
  73. 7.13 DSV
  74. 7.13.1 DSV Company Information
  75. 7.13.2 DSV Business Overview
  76. 7.13.3 DSV Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  77. 7.13.4 DSV Biopharmaceutical Logistic Product Portfolio
  78. 7.13.5 DSV Recent Developments
  79. 7.14 Sinotrans
  80. 7.14.1 Sinotrans Company Information
  81. 7.14.2 Sinotrans Business Overview
  82. 7.14.3 Sinotrans Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Sinotrans Biopharmaceutical Logistic Product Portfolio
  84. 7.14.5 Sinotrans Recent Developments
  85. 7.15 Kerry Logistics
  86. 7.15.1 Kerry Logistics Company Information
  87. 7.15.2 Kerry Logistics Business Overview
  88. 7.15.3 Kerry Logistics Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Kerry Logistics Biopharmaceutical Logistic Product Portfolio
  90. 7.15.5 Kerry Logistics Recent Developments
  91. 7.16 SF Express
  92. 7.16.1 SF Express Company Information
  93. 7.16.2 SF Express Business Overview
  94. 7.16.3 SF Express Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  95. 7.16.4 SF Express Biopharmaceutical Logistic Product Portfolio
  96. 7.16.5 SF Express Recent Developments
  97. 7.17 CEVA
  98. 7.17.1 CEVA Company Information
  99. 7.17.2 CEVA Business Overview
  100. 7.17.3 CEVA Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  101. 7.17.4 CEVA Biopharmaceutical Logistic Product Portfolio
  102. 7.17.5 CEVA Recent Developments
  103. 7.18 CH Robinson
  104. 7.18.1 CH Robinson Company Information
  105. 7.18.2 CH Robinson Business Overview
  106. 7.18.3 CH Robinson Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  107. 7.18.4 CH Robinson Biopharmaceutical Logistic Product Portfolio
  108. 7.18.5 CH Robinson Recent Developments
  109. 7.19 Air Canada Cargo
  110. 7.19.1 Air Canada Cargo Company Information
  111. 7.19.2 Air Canada Cargo Business Overview
  112. 7.19.3 Air Canada Cargo Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Air Canada Cargo Biopharmaceutical Logistic Product Portfolio
  114. 7.19.5 Air Canada Cargo Recent Developments
8 North America
  1. 8.1 North America Biopharmaceutical Logistic Revenue (2021-2032)
  2. 8.2 North America Biopharmaceutical Logistic Revenue by Type (2021-2032)
  3. 8.2.1 North America Biopharmaceutical Logistic Revenue by Type (2021-2026)
  4. 8.2.2 North America Biopharmaceutical Logistic Revenue by Type (2027-2032)
  5. 8.3 North America Biopharmaceutical Logistic Revenue Share by Type (2021-2032)
  6. 8.4 North America Biopharmaceutical Logistic Revenue by Application (2021-2032)
  7. 8.4.1 North America Biopharmaceutical Logistic Revenue by Application (2021-2026)
  8. 8.4.2 North America Biopharmaceutical Logistic Revenue by Application (2027-2032)
  9. 8.5 North America Biopharmaceutical Logistic Revenue Share by Application (2021-2032)
  10. 8.6 North America Biopharmaceutical Logistic Revenue by Country
  11. 8.6.1 North America Biopharmaceutical Logistic Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biopharmaceutical Logistic Revenue by Country (2021-2026)
  13. 8.6.3 North America Biopharmaceutical Logistic Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biopharmaceutical Logistic Revenue (2021-2032)
  2. 9.2 Europe Biopharmaceutical Logistic Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biopharmaceutical Logistic Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biopharmaceutical Logistic Revenue by Type (2027-2032)
  5. 9.3 Europe Biopharmaceutical Logistic Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biopharmaceutical Logistic Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biopharmaceutical Logistic Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biopharmaceutical Logistic Revenue by Application (2027-2032)
  9. 9.5 Europe Biopharmaceutical Logistic Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biopharmaceutical Logistic Revenue by Country
  11. 9.6.1 Europe Biopharmaceutical Logistic Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biopharmaceutical Logistic Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biopharmaceutical Logistic Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biopharmaceutical Logistic Revenue (2021-2032)
  2. 10.2 China Biopharmaceutical Logistic Revenue by Type (2021-2032)
  3. 10.2.1 China Biopharmaceutical Logistic Revenue by Type (2021-2026)
  4. 10.2.2 China Biopharmaceutical Logistic Revenue by Type (2027-2032)
  5. 10.3 China Biopharmaceutical Logistic Revenue Share by Type (2021-2032)
  6. 10.4 China Biopharmaceutical Logistic Revenue by Application (2021-2032)
  7. 10.4.1 China Biopharmaceutical Logistic Revenue by Application (2021-2026)
  8. 10.4.2 China Biopharmaceutical Logistic Revenue by Application (2027-2032)
  9. 10.5 China Biopharmaceutical Logistic Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biopharmaceutical Logistic Revenue (2021-2032)
  2. 11.2 Asia Biopharmaceutical Logistic Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biopharmaceutical Logistic Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biopharmaceutical Logistic Revenue by Type (2027-2032)
  5. 11.3 Asia Biopharmaceutical Logistic Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biopharmaceutical Logistic Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biopharmaceutical Logistic Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biopharmaceutical Logistic Revenue by Application (2027-2032)
  9. 11.5 Asia Biopharmaceutical Logistic Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biopharmaceutical Logistic Revenue by Country
  11. 11.6.1 Asia Biopharmaceutical Logistic Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biopharmaceutical Logistic Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biopharmaceutical Logistic Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biopharmaceutical Logistic Revenue (2021-2032)
  2. 12.2 SAMEA Biopharmaceutical Logistic Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biopharmaceutical Logistic Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biopharmaceutical Logistic Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biopharmaceutical Logistic Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biopharmaceutical Logistic Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biopharmaceutical Logistic Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biopharmaceutical Logistic Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biopharmaceutical Logistic Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biopharmaceutical Logistic Revenue by Country
  11. 12.6.1 SAMEA Biopharmaceutical Logistic Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biopharmaceutical Logistic Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biopharmaceutical Logistic Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst